The study of arrhythmias and electrophysiology encompasses cutting-edge research and therapies to address irregularities in cardiac rhythm. From catheter-based ablation techniques to advanced wearable monitoring devices, progress in this field has improved both diagnosis and treatment precision. Conditions like supraventricular tachycardia and long QT syndrome are increasingly understood through sophisticated electrophysiological testing. Additionally, advancements in cryoablation and robotic catheter navigation have minimized procedural risks while enhancing outcomes. Artificial intelligence is also being integrated into electrophysiology to predict arrhythmia episodes and optimize device programming. As the field grows, it holds immense potential to transform arrhythmia care and cardiac health management globally.
Title : Chronic angina and the health economics of cardiovascular risk reduction in macro- and microvascular coronary disease
Uwe Peter Tigor, Auxilius Pharma, United States, United States
Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms
Guo Wei He, Tianjin University, China
Title : Not So Idiopathic After All: Genotype, Phenotype and IL-1 Blockade Response Converge in Recurrent Pericarditis
burcu yagmur, Kyrenia University Hospital, Cyprus
Title : Beyond the Heart in Cardiovascular Magnetic Resonance Imaging: Prevalence and Clinical Significance of Incidental Extracardiac Findings
burcu yagmur, Kyrenia University Hospital, Cyprus
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States